{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:33:57Z","timestamp":1787931237043,"version":"build-2784847793"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"STDF","doi-asserted-by":"publisher","award":["48092"],"award-info":[{"award-number":["48092"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109081","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:20:25Z","timestamp":1760278825000},"page":"109081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pioneering 1,3,5-triaryl pyrazolines as promising dual inhibitors of COX-2 and 15-LOX endowed with potent anticancer activity: design, synthesis, and in silico study"],"prefix":"10.1016","volume":"166","author":[{"given":"Dina","family":"Abdullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Baraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla A.","family":"Elshanawani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama I.","family":"El-Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109081_bb0005","series-title":"Markers of Inflammation, Immunotoxicity Testing: Methods and Protocols","first-page":"57","volume":"2018","author":"Germolec","year":"1803"},{"issue":"6917","key":"10.1016\/j.bioorg.2025.109081_bb0010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109081_bb0015","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3390\/ijms22105277","article-title":"Regulation of inflammatory reaction in health and disease","volume":"22","author":"Fioranelli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109081_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108398","article-title":"Substituted aryl piperazine ligands as new dual 5-hLOX\/COX-2 inhibitors. Synthesis, biological and computational studies","volume":"159","author":"Mu\u00f1oz-Osses","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109081_bb0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.109081_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01630479","article-title":"New insights into the mode of action of anti-inflammatory drugs","volume":"44","author":"Vane","year":"1995","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bioorg.2025.109081_bb0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.steroids.2019.03.012","article-title":"Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents","volume":"146","author":"Cai","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.bioorg.2025.109081_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2019.03.052","article-title":"New pyrazole derivatives: synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES","volume":"171","author":"Hassan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115443","article-title":"Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines","volume":"256","author":"Abdelkhalek","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103878","article-title":"Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold","volume":"100","author":"Ibrahim","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115724","article-title":"Magic shotgun approach to anti-inflammatory pharmacotherapy: synthesis of novel thienopyrimidine monomers\/heterodimer as dual COX-2 and 15-LOX inhibitors endowed with potent antioxidant activity","volume":"260","author":"Elsayed","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109081_bb0060","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.apsb.2022.01.002","article-title":"Recent development on COX-2 inhibitors as promising anti-inflammatory agents: the past 10 years","volume":"12","author":"Ju","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109081_bb0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bioorg.2019.02.043","article-title":"Novel aryl carboximidamide and 3-aryl-1,2,4-oxadiazole analogues of naproxen as dual selective COX-2\/15-LOX inhibitors: design, synthesis and docking studies","volume":"85","author":"Youssif","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109081_bb0070","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.109081_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108181","article-title":"Exploration of anti-inflammatory activity of pyrazolo[3,4-d]pyrimidine\/1,2,4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: design, synthesis, in silico and in vivo studies","volume":"156","author":"Aziz","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.141504","article-title":"Microwave assisted synthesis, biological assessment and in-silico studies of some new 5,5\u2032-(phenylmethylene)bisuracil and dihydropyrido[2,3-d,6,5-d\u2019]dipyrimidine derivatives as selective COX-2 inhibitors with potential anti-inflammatory activities","volume":"1331","author":"Hayallah","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109081_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108540","article-title":"Novel chalcone candidates as potential in vitro and in vivo anti-inflammatory agents: synthesis, in silico docking, multitarget bioevaluation and molecular dynamic simulation","volume":"161","author":"Ahmed","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109081_bb0090","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/acscatal.3c04954","article-title":"Theoretical study of the arachidonic acid conversion into leukotriene A4 catalyzed by human 5-lipoxygenase: hydroperoxidation and epoxidation mechanisms and arachidonic acid active site access","volume":"14","author":"Cruz","year":"2024","journal-title":"ACS Catal."},{"key":"10.1016\/j.bioorg.2025.109081_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116138","article-title":"Chromone-based small molecules for multistep shutdown of arachidonate pathway: simultaneous inhibition of COX-2, 15-LOX and mPGES-1 enzymes","volume":"266","author":"Elzahhar","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106147","article-title":"Novel 5,6-diphenyl-1,2,4-triazine-3-thiol derivatives as dual COX-2\/5-LOX inhibitors devoid of cardiotoxicity","volume":"129","author":"Saraf","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"42","key":"10.1016\/j.bioorg.2025.109081_bb0105","doi-asserted-by":"crossref","first-page":"30647","DOI":"10.1039\/D4RA04686B","article-title":"NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead","volume":"14","author":"Khalil","year":"2024","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109081_bb0110","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/ijms23031432","article-title":"NSAIDs and Cancer resolution: new paradigms beyond cyclooxygenase","volume":"23","author":"Kolawole","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9255","key":"10.1016\/j.bioorg.2025.109081_bb0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109081_bb0120","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.7150\/ijms.44439","article-title":"The role of cyclooxygenase-2 in colorectal cancer","volume":"17","author":"Sheng","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109081_bb0125","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1080\/14756366.2021.1956912","article-title":"Design and synthesis of novel quinazolinones conjugated ibuprofen, indole acetamide, or thioacetohydrazide as selective COX-2 inhibitors: anti-inflammatory, analgesic and anticancer activities","volume":"36","author":"Sakr","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"06","key":"10.1016\/j.bioorg.2025.109081_bb0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0032-1333293","article-title":"Design, synthesis and evaluation of some novel pyrazoline derivatives as potential anti-inflammatory and antitumor agents","volume":"63","author":"Elbayaa","year":"2013","journal-title":"Drug Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109081_bb0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0975-1483.96621","article-title":"Antitumor, analgesie, and anti-inflammatory activities of synthesized pyrazolines","volume":"4","author":"Jainey","year":"2012","journal-title":"J. Young Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109081_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.22159\/ijpps.2018v10i2.23772","article-title":"A review on anti-inflammatory potential of substituted pyrazoline derivatives synthesised from chalcones","volume":"10","author":"Muralidharan","year":"2018","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109081_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200326","article-title":"Recent advances in the development of celecoxib analogs as anticancer agents: a review","volume":"355","author":"Abdelhaleem","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109081_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bioorg.2015.09.002","article-title":"1-(4-Methane (amino) sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines\/pyrazoles as potential anti-inflammatory agents","volume":"63","author":"Abdellatif","year":"2015","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109081_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors \u2013 current status and future prospects","volume":"36","author":"Dannhardt","year":"2001","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109081_bb0160","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.bmcl.2016.04.046","article-title":"Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: determination of region-specific pyrazole ring formation by NOESY","volume":"26","author":"Abdelall","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109081_bb0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2016.04.049","article-title":"Synthesis of new thiazolo-celecoxib analogues as dual cyclooxygenase-2\/15-lipoxygenase inhibitors: determination of regio-specific different pyrazole cyclization by 2D NMR","volume":"118","author":"Abdelall","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109081_bb0170","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1016\/j.bmcl.2010.07.128","article-title":"Fluorinated 2\u2032-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities","volume":"20","author":"Padhye","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2025.109081_bb0175","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/jm0705096","article-title":"CYP2C9 structure\u2013metabolism relationships: optimizing the metabolic stability of COX-2 inhibitors","volume":"50","author":"Ahlstr\u00f6m","year":"2007","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109081_bb0180","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.bmc.2005.03.054","article-title":"Synthesis and biological evaluation of aromatic enones related to curcumin","volume":"13","author":"Robinson","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109081_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.catcom.2007.06.013","article-title":"SOCl2\/EtOH: catalytic system for synthesis of chalcones","volume":"9","author":"Petrov","year":"2008","journal-title":"Catal. Commun."},{"key":"10.1016\/j.bioorg.2025.109081_bb0190","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00044-009-9248-y","article-title":"Design, synthesis and preliminary antiviral screening of new N-phenylpyrazole and dihydroisoxazole derivatives","volume":"19","author":"Rashad","year":"2010","journal-title":"Med. Chem. Res."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109081_bb0195","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3390\/molecules23071620","article-title":"Chalcone derivatives enhance ATP-binding cassette transporters A1 in human THP-1 macrophages","volume":"23","author":"Teng","year":"2018","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109081_bb0200","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1134\/S1070363223100158","article-title":"Synthesis, biological evaluation, and molecular docking study of new pyrazoline-based compounds","volume":"93","author":"Al-halki","year":"2023","journal-title":"Russ. J. Gen. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109081_bb0205","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s11696-020-01487-6","article-title":"Synthesis, characterization and structure\u2013activity relationship of non-linear optical response of chalcone derivatives with in silico insights","volume":"75","author":"Rai","year":"2021","journal-title":"Chem. Pap."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109081_bb0210","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1038\/s41598-024-55046-0","article-title":"New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study","volume":"14","author":"Serag","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109081_bb0215","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2174\/0929867326666191210104820","article-title":"Lipoxygenase inhibitors as cancer chemopreventives: discovery, recent developments and future perspectives","volume":"28","author":"Mahboubi-Rabbani","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115866","article-title":"Dual COX-2\/15-LOX inhibitors: a new avenue in the prevention of cancer","volume":"261","author":"Aliabadi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109081_bb0225","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2001-12868","article-title":"Effect of celecoxib, a COX-2 inhibitor, in familial adenomatous polyposis","volume":"39","author":"Wullen","year":"2001","journal-title":"Z. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109081_bb0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/13543776.2019.1623880","article-title":"Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)","volume":"29","author":"Mahboubi Rabbani","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109081_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200190","article-title":"Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase-2 inhibitors","volume":"355","author":"Abdelhaleem","year":"2022","journal-title":"Arch. Pharm."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109081_bb0240","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.breast.2010.07.004","article-title":"Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk","volume":"20","author":"Ashok","year":"2011","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109081_bb0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3835(01)00655-3","article-title":"Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells","volume":"172","author":"Goel","year":"2001","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109081_bb0250","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.1021\/acs.chemrev.0c00215","article-title":"Structural and chemical biology of the interaction of cyclooxygenase with substrates and non-steroidal anti-inflammatory drugs","volume":"120","author":"Rouzer","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.109081_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112439","article-title":"Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases","volume":"200","author":"Elzahhar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103505","article-title":"Click chemistry synthesis, biological evaluation and docking study of some novel 2\u2032-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents","volume":"95","author":"Boshra","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113457","article-title":"Novel 1,2,4-triazine-quinoline hybrids: the privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition","volume":"219","author":"Ghanim","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109081_bb0270","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3390\/molecules25153374","article-title":"Fatty acid allosteric regulation of C-H activation in plant and animal lipoxygenases","volume":"25","author":"Offenbacher","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109081_bb0285","unstructured":"the Molecular Modeling Group of the SIB | Swiss Institute of Bioinformatics, SwissADME. http:\/\/www.swissadme.ch\/."},{"issue":"18","key":"10.1016\/j.bioorg.2025.109081_bb0295","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1016\/j.bmc.2011.11.064","article-title":"Softening the Rule of Five\u2014where to draw the line?","volume":"20","author":"Petit","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0300","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bioorg.2018.11.030","article-title":"1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: design, synthesis, COX-1\/2 inhibitory activity and molecular docking study","volume":"84","author":"Sakr","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2024.100475","article-title":"A novel pyrazole derivative as COVID-19 main protease inhibitor: synthesis, quantum computational studies, pharmacokinetic properties, drug likeness, molecular docking and dynamics simulation; a CADD approach","volume":"8","author":"Rekharani","year":"2024","journal-title":"Chem. Phys. Impact"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109081_bb0310","first-page":"1","article-title":"In silico ADME\/T properties of quinine derivatives using SwissADME and pkCSM webservers","volume":"42","author":"Lohohola","year":"2021","journal-title":"Int. J. Trop. Dis. Health"},{"key":"10.1016\/j.bioorg.2025.109081_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104527","article-title":"Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy","volume":"107","author":"Upadhyay","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109081_bb0320","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1055\/a-2007-2958","article-title":"Ligand-free palladium-catalyzed substoichiometric base mediated carbonylation of aryl iodides with alkenylboronic acids under ambient conditions","volume":"34","author":"Tang","year":"2023","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2025.109081_bb0325","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.molstruc.2017.01.080","article-title":"Synthesis, crystal structure, Hirshfeld surface analysis, spectroscopic characterization, reactivity study by DFT and MD approaches and molecular docking study of a novel chalcone derivative","volume":"1135","author":"Arshad","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109081_bb0330","series-title":"4-(c2-6alkoxy)-Substituted Chalcones as Therapeutic Agents","author":"Potter","year":"2006"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109081_bb0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/hc-2017-0034","article-title":"13C NMR spectroscopy of heterocycles: 1-phenyl-3-aryl\/t-butyl-5-arylpyrazoles","volume":"23","author":"Hockstedler","year":"2017","journal-title":"Heterocycl. Commun."},{"issue":"41","key":"10.1016\/j.bioorg.2025.109081_bb0340","doi-asserted-by":"crossref","first-page":"8273","DOI":"10.1039\/D4OB01352B","article-title":"A multi-component synthetic route for 2-pyrazolines via acceptorless dehydrogenation of alcohols using homogeneous Ni (ii) catalysts","volume":"22","author":"Kukreti","year":"2024","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0345","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molstruc.2018.07.052","article-title":"Spectroscopic studies of aryl substituted 1-phenyl-2-pyrazolines: steric and electronic substitution effects","volume":"1173","author":"Soltani","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109081_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104883","article-title":"Design, synthesis, biological evaluation, and computational studies of novel thiazolo-pyrazole hybrids as promising selective COX-2 inhibitors: implementation of apoptotic genes expression for ulcerogenic liability assessment","volume":"111","author":"Marzouk","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1635706","article-title":"Mastering the art of sectioning: a comprehensive guide to slide-microtome technology and histological applications","volume":"12","author":"Abd El-Aziz","year":"2025","journal-title":"Front. Vet. Sci."},{"issue":"23","key":"10.1016\/j.bioorg.2025.109081_bb0360","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1016\/j.bmcl.2010.07.054","article-title":"The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life","volume":"20","author":"Wang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109081_bb0365","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nsb1297-1003","article-title":"The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity","volume":"4","author":"Gillmor","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bioorg.2025.109081_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108694","article-title":"Synthesis and apoptotic induction of sulfonamide-based chalcone hybrids as first-in-class dual histone deacetylase-carbonic anhydrase inhibitors with potential anti-tubulin activity","volume":"163","author":"Mohamed","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117891","article-title":"Unveiling ortho-phenolic Mannich ciprofloxacin-chalcone conjugates with potential antineoplastic activity: synthesis, mechanistic study, in silico docking and molecular dynamic simulation","volume":"296","author":"Abdel-Rahman","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109081_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108671","article-title":"Exploitation of novel pyrazolo[3,4-d]pyrimidine scaffold tethered to thiazole as potential EGFR\/HER2 dual kinase inhibitor to overcome lapatinib resistant breast cancer: design, synthesis, in silico docking and molecular dynamic simulation","volume":"163","author":"Salem","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109081_bb0385","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13568-025-01835-3","article-title":"Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa","volume":"15","author":"Alyahyawy","year":"2025","journal-title":"AMB Express"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109081_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70101","article-title":"Repurposing nitroimidazoles: a new frontier in combatting bacterial virulence and quorum sensing via in silico, in vitro, and in vivo insights","volume":"86","author":"Khafagy","year":"2025","journal-title":"Drug Dev. Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:19:21Z","timestamp":1763666361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":75,"alternative-id":["S0045206825009617"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109081","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pioneering 1,3,5-triaryl pyrazolines as promising dual inhibitors of COX-2 and 15-LOX endowed with potent anticancer activity: design, synthesis, and in silico study","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109081"}}